Delivery Order SPE2DB25D3012-SPE2DB25FXAMK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $10,920.04. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,024.58 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180 count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order valued at $2,239.56 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,823.85 on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count). This competitively awarded, firm fixed-price delivery order is expected to be completed by August 13, 2025, with fulfillment occurring at the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) on August 27, 2025, with a ceiling value of $1,535.39 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $76,733.23 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAMKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,622.60 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitive, non-set-aside award is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, under a firm fixed-price delivery order contract type. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical supplier for federal medical procurement, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The pharmaceutical supply supports the Defense Health Agency and other federal healthcare customers through DLA's strategic contracting approach for global pharmaceutical distribution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/25/25 |